Breggin, PR. (2016). Rational Principles of Psychopharmacology for Therapists, Healthcare Providers and Clients. J Contemp Psychother 46:1–13. Because the epidemic dispensing of psychiatric drugs is based on misinformation, it is important for all health professionals, consumers, and most citizens (including patients and their family members) to have a more rational […]
Read More
The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs. Children & Society, 28, (2014) pp. 231-241 Peter R. Breggin, MD Based on the author’s extensive clinical, forensic and research experience, this article addresses the scientific and moral question of whether it is ever in […]
Read More
Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication. International Journal of Risk & Safety in Medicine, 23: 193-200. Peter R. Breggin, MD Abstract: Understanding the hazards associated with long-term exposure to psychiatric drugs is very important but rarely emphasized in the scientific literature and clinical […]
Read More
Ethical Human Psychology and Psychiatry, Volume 12, Number 2, 2010. Peter R. Breggin, MD The newer antidepressants frequently cause suicide, violence, and manic-like symptoms of activation or overstimulation, presenting serious hazards to active-duty soldiers who carry weapons under stressful conditions. These antidepressant-induced symptoms of activation can mimic posttraumatic stress disorder […]
Read More
“Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs,” International Journal of Risk & Safety in Medicine, 19, 3-15, 2007. ABSTRACT: Why do so many individuals persist in taking psychoactive substances, including psychiatric drugs, after adverse mental and behavioral effects have become severe and even disabling? The author has previously proposed the […]
Read More
“Drug Company Suppressed Data on Paroxetine-Induced Stimulation: Implications for Violence and Suicide”, Ethical Human Psychology and Psychiatry, 8, 255-263, 2006. Peter Breggins Paxil Special Report III.pdf
Read More
“How GlaxoSmithKline Suppressed Data on Paxil-Induced Akathisia: Implications for Suicidality and Violence”, Ethical Human Psychology and Psychiatry, 8, 91-100, 2006. Peter Breggins Paxil special report II.pdf
Read More
“Court Filing Makes Public My Previously Suppressed Analysis of Paxil’s Effects.” Ethical Human Psychology and Psychiatry, 8, 77-84, 2006. courtfiling.pbreggin.2006.pdf
Read More
More focus is needed on the risk of activation or stimulation as described in the new class of warnings from the Food and Drug Administration, including anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania and other unusual changes of behavior, worsening of depression and suicidal ideation. […]
Read More
Information on antidepressant-induced akathisia comes to light with court filing in Lacuzong case. courtfiling.pbreggin.2006.pdf
Read More